Keywords: prostatic neoplasms; magnetic resonance imaging; ultrasonography; biopsy; diagnostic imaging; CS-PCA; clinically significant PCA; MRI; magnetic resonance imaging; PCA; prostate cancer; PI-RADS⢠v2; Prostate Imaging Reporting and Data System, version 2;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Bladder carcinoma; Cystectomy; Sexual function preserving; Prostate sparing; Neobladder; BC; bladder cancer; BCG; bacillus Calmette-Guérin; CSM; Cancer specific mortality; CSS; Cancer specific survival; CIS; carcinoma in situ; CIC; clean intermittent cat
Keywords: prostatic neoplasms; image-guided biopsy; magnetic resonance imaging; ultrasonography; diagnostic imaging; AS; anterior stroma; FUS-GB; MRI/ultrasound fusion guided biopsy; GS; Gleason score; mp-MRI; multiparametric MRI; MRI; magnetic resonance imaging; P
Keywords: PCa; prostate cancer; PSA; prostate specific antigen; DRE; digital rectal examination; PSAD; prostate specific antigen density; BPH; benign prostatic hyperplasia; AUC; area under curve; KATH; Komfo Anokye Teaching Hospital; ROC; receiver operating charact
Keywords: prostatic neoplasms; mass screening; mortality; failure to rescue; health care; early detection of cancer; DRE; digital rectal examination; ERSPC; European Randomized study of Screening for Prostate Cancer; PSA; prostate specific antigen; TRUS; transrecta
Keywords: cost-benefit analysis; patient preference; diagnostic imaging; prostate; biopsy; HSA; health savings account; MRI; magnetic resonance imaging; MR-US; magnetic resonance-ultrasound; TRUS; transrectal ultrasound;
Keywords: prostatic neoplasms; magnetic resonance imaging; neoplasm staging; AS; active surveillance; DWI; diffusion weighted imaging; EPE; extraprostatic extension; LN; lymph node; MR; magnetic resonance; PCa; prostate cancer; PI-RADS; Prostate Imaging Reporting a
Keywords: prostatic neoplasms; prostatectomy; elasticity imaging techniques; diagnostic imaging; pathology; DRE; digital rectal examination; GS; Gleason score; LRP; laparoscopic radical prostatectomy; MRI; magnetic resonance imaging; PCa; prostate cancer; PSA; pros
Keywords: biopsy; internship and residency; ultrasound; high-intensity focused; transrectal; neoplasm grading; prostatic neoplasms; PGY; postgraduate year; PSA; prostate specific antigen; RP; radical prostatectomy; TRUS; transrectal ultrasound;
Keywords: prostatic neoplasms; urinary tract; microbiota; inflammation; bacteria; BPH; benign prostatic hyperplasia; ISUP; International Society of Urological Pathology; OTU; operational taxonomic unit; PCR; polymerase chain reaction; PSA; prostate specific antigen
Keywords: 5α-adiol; 5α-androstan-3α,17β-diol; 5β-adiol; 5β-androstan-3α,17β-diol; A; androsterone; ANOVA; analysis of variance; AUC; area under the curve; CV%; coefficient of variation; CV; cross validation; DA; discriminant analysis; DHEA; dehydroepiandros
Keywords: Antibiotherapy; BPH; Prostate cancer; PSA; fPSA; free prostate-specific antigen; IPSS; International Prostate Symptom Score; Qmax; maximum flow rates; PCa; prostate cancer; PSA; prostate-specific antigen; PSAD; prostate-specific antigen density; TRUS; tra
Keywords: prostate; biopsy; complications; infection; ultrasound; high-intensity focused; transrectal; AUA; American Urological Association; PNB; prostate needle biopsy; TRUS; transrectal ultrasound;
Keywords: CAPRA; Clinical risk; Prostate cancer risk prediction; Transrectal ultrasound; TRUS;
Keywords: anti-bacterial agents; biopsy; prostate; antibiotic prophylaxis; microbial sensitivity tests; AUA; American Urological Association; CKD; chronic kidney disease; ED; emergency department; FQ; fluoroquinolone; IM; intramuscular; MRI; magnetic resonance imag
Keywords: prostatic neoplasms; biopsy; diagnosis; mortality; risk; ACM; all-cause mortality; DRE; digital rectal examination; PCa; prostate cancer; PCSM; prostate cancer specific mortality; PSA; prostate specific antigen; TRUS; transrectal ultrasound;
Keywords: prostatic neoplasms; magnetic resonance imaging; image-guided biopsy; diagnostic imaging; risk; CS; clinically significant; DRE; digital rectal examination; FBx; MRI/TRUS fusion-guided biopsy; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; P
Keywords: prostatic neoplasms; biopsy; magnetic resonance imaging; ultrasound; high-intensity focused; transrectal; prognosis; CCI; cancer core involvement; CCL; cancer core length; GS; Gleason score; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; PCa
Keywords: prostatic hyperplasia; laser therapy; learning curve; mentors; urinary incontinence; BPH; benign prostatic hyperplasia; CD; case difficulty; GMP; grossly multinodular prostate; HoLEP; holmium laser enucleation of prostate; LCC; learning curve characteriza
Keywords: prostatic neoplasms; photochemotherapy; WST11 compound; therapeutic occlusion; treatment outcome; AS; active surveillance; CSC; clinically significant cancer; FT; focal therapy; HIFU; high intensity focused ultrasound; IIEF; International Index of Erectil
Keywords: prostatic neoplasms; biopsy; magnetic resonance imaging; diagnostic imaging; standards; CCF; Cleveland Clinic Foundation; DCE; dynamic contrast enhanced T1-weighted imaging; DWI; diffusion-weighted imaging; GG; grade group; JHH; Johns Hopkins Hospital; mp
Keywords: Pca; prostate cancer; mpMRI; multiparametric magnetic resonance imaging; EBRT; external beam radiation therapy; DRE; digital rectal examination; TRUS; transrectal ultrasonography; PSA; prostate-specific antigen; GS; Gleason score; NCCN; National comprehen
Keywords: PSA; TRUS; Prostatic; Carcinoma; Treatment; Antigène spécifique de la prostate; Ãchographie; Traitement; Adénocarcinome prostatique;
Keywords: prostatic neoplasms; genomics; biological assay; prostatectomy; watchful waiting; AP; adverse pathology; AS; active surveillance; CAPRA; Cancer of the Prostate Risk Assessment; GPS; Genomic Prostate Score; LFP; likelihood of favorable pathology; LIR; low
Keywords: prostate; adenocarcinoma; biopsy; magnetic resonance imaging; ultrasound, high-intensity focused, transrectal; CDR; cancer detection rate; DCE; dynamic contrast enhanced; FB; fusion guided biopsy; LIJ; Long Island Jewish Medical Center; MP; multiparametri
Keywords: testis; infertility; male; azoospermia; ejaculatory ducts; sperm retrieval; CFTR; cystic fibrosis transmembrane conductance regulator; EDO; ejaculatory duct obstruction; FSH; follicle-stimulating hormone; HPT; hypothalamic-pituitary-testis; ICSI; intracyt
Keywords: prostate; prostatic neoplasms; biopsy; diagnosis; prostatectomy; MCCL; maximum cancer core length; TRUS; transrectal ultrasound; TTPM; transperineal template prostate mapping;
Keywords: Biomarkers; Prostate; Screening; TRUS; PSA; PCA3; TMPRSS2:ERG; Prostate Health Index;
Keywords: prostate; prostatic neoplasms; quality of health care; registries; health information management; AUA; American Urological Association; BCBSM; Blue Cross Blue Shield of Michigan; CQI; Collaborative Quality Initiative; MUSIC; Michigan Urological Surgery Im
Keywords: prostate; prostatic neoplasms; biopsy; physician's practice patterns; Michigan; DRE; digital rectal examination; MUSIC; Michigan Urological Surgery Improvement Collaborative; PCa; prostate cancer; PSA; prostate specific antigen; TRUS; transrectal ultrasou
Keywords: prostatic neoplasms; image-guided biopsy; magnetic resonance imaging; ultrasound; high-intensity focused; transrectal; 3D; 3-dimensional; DRE; digital rectal examination; MP; multiparametric prostate; MR; magnetic resonance; MRI; magnetic resonance imagin
Keywords: prostatic hyperplasia; transurethral resection of prostate; lasers, solid-state; BPH; benign prostatic hyperplasia; HoLEP; holmium laser enucleation of the prostate; PKRP; plasmakinetic resection of the prostate; PSA; prostate specific antigen; PVR; post-
Clinical evaluation of the iXip index to reduce prostate re-biopsies
Keywords: iXip; PSA-IgM; Re-biopsy; Prostate cancer; Diagnosis; ASAP; atypical small acinar proliferation; AUC; area under the curve; BPH; benign prostatic hyperplasia; DRE; digital rectal examination; HGPIN; high-grade prostatic intra-epithelial neoplasia; mpMRI;
National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
Keywords: prostatic neoplasms; watchful waiting; prostatectomy; neoplasm recurrence; local; risk factors; AS; active surveillance; FIR; favorable IR; GG; Grade Group; IR; intermediate risk; LR; low risk; MRI; magnetic resonance imaging; NCCN®; National Comprehensi
T2E (TMPRSS2-ERG) fusion transcripts are associated with higher levels of AMACR mRNA and a subsequent prostate cancer diagnosis in patients with atypical small acinar proliferation
Keywords: TMPRSS2; androgen-regulated transmembrane protease serine 2 gene; ERG and ETV1; genes from the ETS transcription factor family; T2E; TMPRSS2-ERG; T2ETV1; TMPRSS2-ETV1; PC; prostate cancer; ASAP; atypical small acinar proliferation; AMACR; alpha-methylacyl
Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound
Keywords: prostatic neoplasms; high-intensity focused ultrasound ablation; magnetic resonance imaging; quality of life; surveys and questionnaires; csPC; clinically significant PC; FT; focal therapy; HADS-D; Hospital and Anxiety and Depression Score, German version
Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?
Keywords: prostatic neoplasms; image-guided biopsy; neoplasm grading; pathology; surgical; risk; CDR; cancer detection rate; CS; clinically significant; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; NIH; National Institutes of Health; NSIL; nonSIL; P
Preliminary study on TRUs utilization in a small modular Th-based molten salt reactor (smTMSR)
Keywords: Small modular reactors; Molten salt reactors; Thorium fuel cycle; TRUs;
Prospective Monitoring and Adapting Strategies for Prevention of Infection Following Transrectal Prostate Procedures
Keywords: drug resistance; bacterial; fiducial markers; infection; prostate; biopsy; FQ; fluoroquinolone; IM; intramuscular; IV; intravenous; TMP-SMX; trimethoprim-sulfamethoxazole; TRPX; transrectal prostate procedure; TRUS; transrectal ultrasound; UTI; urinary tr
The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer
Keywords: CADMUS; Prostate cancer; Multiparametric ultrasound; Multiparametric MRI; Targeted prostate biopsy; TRUS;
68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study
Keywords: prostatic neoplasms; positron emission tomography computed tomography; glutamate carboxypeptidase II; human; biopsy; diagnostic imaging; BPH; benign prostatic hyperplasia; CT; computerized tomography; 68Ga-PSMA; 68gallium labeled PSMA; GS; Gleason score;
Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration
Keywords: prostatic neoplasms; urine; DNA methylation; polymerase chain reaction; diagnosis; ddPCRâ¢; droplet digital PCR; DRE; digital rectal examination; GS; Gleason score; NPV; negative predictive value; PBL; peripheral blood leukocyte; PCa; prostate cancer; PC
ACR Appropriateness Criteria® Hematospermia
Keywords: Appropriateness Criteria; Appropriate Use Criteria; AUC; hematospermia; hemospermia; MRI; TRUS; ultrasound;
Prostate cancer diagnosis: Efficacy of a simple electromagnetic MRI-TRUS fusion method to target biopsies
Keywords: mpMRI; multi-parametric magnetic resonance imaging; MRI; magnetic resonance imaging; PSA; prostate-specific antigen; SB; systematic biopsy; TB; targeted biopsy; TRUS; transrectal ultrasound; MRGB; MRI-guided biopsy; Neoplasms; Prostate; Ultrasonography; I
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer
Keywords: prostatic neoplasms; electroporation; toxicity; questionnaires; technology assessment; biomedical; FACT-P; Functional Assessment of Cancer Therapy for Prostate; HIFU; high intensity focused ultrasound; IDEAL; Idea, Development, Evaluation, Assessment and
Transrectal Ultra Sonography based evidence of Ksharasutra therapy for Fistula-in-ano - A case series
Keywords: Bhagandara; Fistula-in-ano; Ksharasutra; TRUS;
Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results
Keywords: prostatic hyperplasia; urinary bladder neck obstruction; ablation techniques; water; transurethral resection of prostate; BPH; benign prostatic hyperplasia; CPU; conformal planning unit; IIEF; International Index of Erectile Function; I-PSS; International
Prospective Evaluation of PI-RADS⢠Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System
Keywords: prostatic neoplasms; early detection of cancer; reference standards; diagnostic imaging; biopsy; CDR; cancer detection rate; CS; clinically significant; DCE; dynamic contrast enhanced; DWI; diffusion-weighted imaging; ISUP; International Society of Urolog
A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study
Keywords: DCE; Dynamic contrast-enhanced magnetic resonance imaging; DRE; Digital rectal examination; DWI; Diffusion-weighted imaging; mpMRI; Multiparametric magnetic resonance imaging; PI-RADS; Prostate imaging reporting and data system; PSA; Prostate-specific ant
High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results
Keywords: AJCC; American Joint Committee on Cancer; BED; Biologically effective dose; CTAE v4.02; Common Toxicity Criteria for Adverse Event, version 4.02; CTV; Clinical target volume; D90; The dose that covers 90% volume of CTV; D100 urethra; Dose delivered to 100